With Analysis of 20 Genomes, Duke Team Demonstrates Proof of Concept for Sequencing Disease Cohorts
September 21, 2010
With Analysis of 20 Genomes, Duke Team Demonstrates Proof of Concept for Sequencing Disease Cohorts
The study, which sequenced and characterized 20 individual genomes, is part of a larger effort at Duke that aims to sequence around 200 genomes and 500 exomes from various disease cohorts including schizophrenia, epilepsy, ALS, and HIV.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NHGRI's ClinSeq Project Moves into Exome, Whole-Genome Sequencing on Illumina GA
June 8, 2010 / In Sequence - Helicos Adds Illumina, Life Tech as Defendants in PacBio Patent Lawsuit
October 26, 2010 / In Sequence - Covaris and Illumina to Co-Market Sample-Prep Tools, Sequencers
September 28, 2010 / In Sequence - BGI Americas Banks on Chinese Institute's Vast Sequencing and Bioinformatics Capacity
September 21, 2010 / In Sequence - Illumina Offers $10K Human Genome for Research; Sees 'All-In' $1,000 Genome in Three to Five Years
September 21, 2010 / In Sequence